HSA — authorised 23 February 2015
- Marketing authorisation holder: NOVARTIS PHARMS CORP
- Status: likely_approved
🇸🇬 Farydak in Singapore
HSA authorised Farydak on 23 February 2015
Marketing authorisation
Farydak in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Singapore
Frequently asked questions
Is Farydak approved in Singapore?
Yes. HSA authorised it on 23 February 2015.
Who is the marketing authorisation holder for Farydak in Singapore?
NOVARTIS PHARMS CORP holds the Singaporean marketing authorisation.